Acura Pharmaceuticals reported 167K in Cash and Equivalent for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Acelrx Pharmaceuticals ACRX:US $ 21.82M 9.16M
Intra Cellular Therapies ITCI:US $ 77.24M 52.06M
Nektar Therapeutics NKTR:US $ 77.54M 9.55M
Rigel Pharmaceuticals RIGL:US $ 27.2M 2.52M
Shionogi 4507:JP Y 204629M 49791M
Teva Pharmaceutical TEVA:IT 2.06B 117M
Xeris Pharmaceuticals Inc XERS:US $ 103.77M 36.5M